Whole‐genome circulating tumor DNA methylation landscape reveals sensitive biomarkers of breast cancer

The changes in circulating tumor DNA (ctDNA) methylation are believed to be early events in breast cancer initiation, which makes them suitable as promising biomarkers for early diagnosis. However, applying ctDNA in breast cancer early diagnosis remains highly challenging due to the contamination of...

Descripción completa

Detalles Bibliográficos
Autores principales: Hai, Luo, Li, Lingyu, Liu, Zongzhi, Tong, Zhongsheng, Sun, Yingli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9205580/
https://www.ncbi.nlm.nih.gov/pubmed/35756163
http://dx.doi.org/10.1002/mco2.134

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9205580/
https://www.ncbi.nlm.nih.gov/pubmed/35756163
http://dx.doi.org/10.1002/mco2.134

Ejemplares similares